AddLife finishes 2024 with a very strong fourth quarter. Organic growth was 9%, EBITA increased by 24%, and cash flow improved by 49%. The companies within AddLife performed very well, driven by positive demand development and dedicated, long-term efficiency efforts.
A European partner in Life Science
Our vision is to improve people's lives by being a leading, value-adding partner in Life Science
Year-end Report Q4 2024
Share price
Press Releases
Report
Calendar
-
![Fredrik Dalborg Addlife 250120 2]()
-
Biomedica Medizinprodukte received ISO37001
Biomedica Medizinprodukte ISO37001Biomedica Medizinprodukte GmbH received an ISO37001 – Anti-Bribery Management System certification by QualityAustria
This milestone is a testament to our unwavering commitment to EthicalBusiness practices, transparency, and accountability. By implementing the rigorous standards of ISO37001, we reinforce a culture of integrity and ensure robust safeguards against bribery and corruption across all operations.
![IMG 0836]()
Our business areas
MEDTECH
In the Medtech business area, the subsidiaries offer products and services in medical technology, as well as assistive equipment and digital solutions for use in home care. Medtech has two business units - Hospital and Homecare. The Medtech offering mainly focuses on publicly funded healthcare, home care and social care in Europe.
Read more
LABTECH
The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. The business area consists of two business units: Biomedical and Research and Diagnostics. The most important customer groups are hospital laboratories, academic research and pharmaceutical companies in Europe.
Read moreJoin the AddLife group
Do you have a Life Science company with opportunities to grow? We offer an attractive option with a decentralized business model where we combine the strength of a large enterprise with the dedication and business skills of an entrepreneur. As an AddLife subsidiary, you are responsible for your business activities within the AddLife requirements for growth, profitability and sustainable development.
News from our subsidiaries
13 February 2025
MBA SURGICAL EMPOWERMENT partners with CMR Surgical
CMR Surgical and MBA SURGICAL EMPOWERMENT partner to expand the presence of the Versius robot in the Iberian peninsula
MBA
19 December 2024 | MBA
MBA MBA SURGICAL EMPOWERMENT Portugal team helps with recovery of a deforested area
During the day, MBA Portugal planted 400 native species trees, reaffirming our commitment to sustainable development and biodiversity.
05 December 2024 | Biomedica
Biomedica Medizinprodukte ISO37001
Biomedica Medizinprodukte GmbH has achieved an ISO37001 – Anti-Bribery Management System certification by QualityAustria
15 November 2024 | Svan Care
Svancare donates assistive devices to Ukraine
Svancare, together with Korpinen, has initiated a collaboration and donated assistive devices to Ukraine through the non-profit organization Operation Change.
Sustainability for AddLife
Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value adding provider in Life Science. AddLife´s approach to sustainability is identified through three impact areas where we can have the greatest contribution to a long-term lasting business and society.
